
Bioventus BVS
$ 11.0
3.0%
Annual report 2025
added 03-05-2026
Bioventus Operating Cycle 2011-2026 | BVS
Annual Operating Cycle Bioventus
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 259 | 261 | 267 | 241 | 141 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 267 | 141 | 234 |
Quarterly Operating Cycle Bioventus
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 284 | 268 | 294 | 264 | 256 | 300 | 299 | 255 | 272 | - | 249 | 225 | 234 | - | 195 | 180 | 241 | - | 207 | 289 | 113 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 300 | 113 | 246 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 17.65 | 3.67 % | $ 186 M | ||
|
Agilent Technologies
A
|
161 | $ 117.92 | 0.31 % | $ 35.8 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 429.45 | -0.2 % | $ 12.4 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.06 | -19.38 % | $ 376 M | ||
|
NeoGenomics
NEO
|
102 | $ 8.81 | -0.56 % | $ 1.13 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.23 | -2.72 % | $ 408 M | ||
|
Natera
NTRA
|
81.5 | $ 214.17 | 3.58 % | $ 21.1 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.04 | 2.23 % | $ 20 B | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Personalis
PSNL
|
55.8 | $ 5.98 | 7.55 % | $ 354 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 20.87 | 0.82 % | $ 1.11 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 471.04 | 0.93 % | $ 178 B | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.62 | 2.79 % | $ 61.9 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 24.93 | 1.34 % | $ 692 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 59.92 | 5.68 % | $ 3.58 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 184.9 | -0.26 % | $ 9.16 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Waters Corporation
WAT
|
834 | $ 349.35 | 1.92 % | $ 20.8 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.16 | 1.74 % | $ 458 M | ||
|
Guardant Health
GH
|
128 | $ 91.12 | 1.78 % | $ 11.4 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 122.9 | 1.3 % | $ 10.1 B | ||
|
Illumina
ILMN
|
198 | $ 140.99 | 1.38 % | $ 22.4 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.16 | 3.2 % | $ 215 M | ||
|
Interpace Biosciences
IDXG
|
96 | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
204 | $ 2.2 | 0.51 % | $ 5.05 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 86.08 | 0.3 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 258.55 | 0.55 % | $ 21.5 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.24 | -0.27 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 191.08 | 0.13 % | $ 21.2 B |